The purpose of this chapter is to describe a method of calculation leading to what it could be called a “quantitative pharmacokinetics,” since the plasma drug profiles are reckoned. This is the answer to the questions set by the U.S. Food and Drug Administration (FDA) in the late 1980s about a possible correlation between the
in vivo
tests and the
in vitro
tests for oral dosage forms with controlled release.